BioPace
PrivateLast Round
Grant
Apr 1, 2020
Est. Valuation
$3M
Total Funding Raised
$270,000
Company Overview
BioPace operates in Healthcare & Life Sciences and is based in Los Angeles, California. Its latest recorded funding round was an Accelerator round in November 2013.
BioPace is a biotechnology company developing a hardware-free biological pacemaker technology to complement or replace traditional implantable electronic pacemakers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioPace Comparables
Compare BioPace with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PacingCure B.V. | 82% | |
| Cortex, Inc. | 64% | |
| CAIRDAC | 63% |
For institutional investors. Book with your work email.
BioPace Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 1, 2020 | ||||
| Accelerator | Nov 1, 2013 |
For institutional investors. Book with your work email.
BioPace Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Leonhardt Ventures | Accelerator |
| Cal-X Stars Business Accelerator | Accelerator |
| National Institutes of Health (NIH) | Grant |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 1, 2013
$270K round led by Leonhardt Ventures.
For institutional investors. Book with your work email.
BioPace Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BioPace's valuation, stock price, and market status.
Is BioPace a public or private company?
BioPace is a private company.
What is the current stock price of BioPace?
BioPace is a private company, so its shares have no public market price. Caplight tracks BioPace's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BioPace worth (valuation)?
BioPace's valuation is estimated at $3.0M based on funding round data.
Can I buy BioPace stock?
BioPace shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BioPace's last funding round?
BioPace's most recent funding round was Grant on April 1, 2020.
Who are the main investors in BioPace?
Key investors in BioPace include Leonhardt Ventures.
Will BioPace IPO soon?
No public IPO plans have been announced for BioPace.
How can I track BioPace secondary market activity?
Caplight tracks bids, offers, and trades in BioPace's shares on secondary markets.